BMC Pregnancy Childbirth
October 2024
Topic: To evaluate the efficacy and safety of anti-VEGF and panretinal photocoagulation (PRP) for the treatment of proliferative diabetic retinopathy (PDR). The outcomes examined are changes in best-corrected visual acuity (BCVA), neovascularization (NV), central macular thickness (CMT), and adverse outcomes.
Clinical Relevance: Diabetic retinopathy is the leading cause of blindness in working-aged adults globally.